tirzepatide and tamoxifen Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes weight loss (Mounjaro, Zepbound)—can also shrink breast cancer tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Clinical CYP2D6 Genotyping to Personalize
Description
Understanding this connection helps explain why these medications support metabolic health beyond weight loss alone
Accumulation of methylglyoxal (MG) contributes to glucotoxicity and mediates beta cell apoptosis
Tarik Husains Clinic
Precautions: Consult with a healthcare provider before starting therapy
The heart doesn't distinguish between an electrolyte that's too high and one that's too low
